Artivion, Inc. (AORT)
35.31
-1.22
(-3.34%)
USD |
NYSE |
Mar 20, 16:00
35.32
+0.01
(+0.03%)
After-Hours: 20:00
Artivion Research and Development Expense (Quarterly) : 9.122M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 267.70M |
| NeuroOne Medical Technologies Corp. | 1.390M |
| Zimmer Biomet Holdings, Inc. | 118.80M |
| PetVivo Holdings, Inc. | 0.323M |
| Nutriband, Inc. | 0.4571M |